v3.25.4
Revenues - Schedule of Disaggregation of Revenue by Product and by Geographic Area (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Disaggregation of Revenue [Line Items]      
Total revenues $ 36,751 $ 33,424 $ 28,190
U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 26,419 23,863 19,806
ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 10,332 9,561 8,384
Prolia      
Disaggregation of Revenue [Line Items]      
Total revenues 4,414 4,374 4,048
Prolia | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 2,978 2,885 2,733
Prolia | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 1,436 1,489 1,315
Repatha      
Disaggregation of Revenue [Line Items]      
Total revenues 3,016 2,222 1,635
Repatha | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,663 1,139 793
Repatha | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 1,353 1,083 842
Otezla      
Disaggregation of Revenue [Line Items]      
Total revenues 2,265 2,126 2,188
Otezla | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,839 1,699 1,777
Otezla | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 426 427 411
ENBREL      
Disaggregation of Revenue [Line Items]      
Total revenues 2,226 3,316 3,697
ENBREL | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 2,199 3,288 3,650
ENBREL | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 27 28 47
EVENITY      
Disaggregation of Revenue [Line Items]      
Total revenues 2,100 1,563 1,160
EVENITY | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,600 1,131 809
EVENITY | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 500 432 351
XGEVA      
Disaggregation of Revenue [Line Items]      
Total revenues 2,084 2,225 2,112
XGEVA | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,355 1,507 1,527
XGEVA | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 729 718 585
TEPEZZA      
Disaggregation of Revenue [Line Items]      
Total revenues 1,903 1,851 448
TEPEZZA | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,758 1,835 441
TEPEZZA | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 145 16 7
BLINCYTO      
Disaggregation of Revenue [Line Items]      
Total revenues 1,559 1,216 861
BLINCYTO | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,049 800 566
BLINCYTO | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 510 416 295
Nplate      
Disaggregation of Revenue [Line Items]      
Total revenues 1,524 1,456 1,477
Nplate | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,027 970 996
Nplate | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 497 486 481
TEZSPIRE      
Disaggregation of Revenue [Line Items]      
Total revenues 1,478 972 567
TEZSPIRE | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,478 972 567
TEZSPIRE | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 0 0 0
KYPROLIS      
Disaggregation of Revenue [Line Items]      
Total revenues 1,412 1,503 1,403
KYPROLIS | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 913 948 921
KYPROLIS | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 499 555 482
Aranesp      
Disaggregation of Revenue [Line Items]      
Total revenues 1,389 1,342 1,362
Aranesp | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 416 386 452
Aranesp | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 973 956 910
KRYSTEXXA      
Disaggregation of Revenue [Line Items]      
Total revenues 1,340 1,185 272
KRYSTEXXA | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 1,340 1,185 272
KRYSTEXXA | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 0 0 0
Vectibix      
Disaggregation of Revenue [Line Items]      
Total revenues 1,175 1,045 984
Vectibix | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 604 519 461
Vectibix | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 571 526 523
Other products      
Disaggregation of Revenue [Line Items]      
Total revenues 7,263 5,630 4,696
Other products | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 5,437 4,037 3,307
Other products | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 1,826 1,593 1,389
Product sales      
Disaggregation of Revenue [Line Items]      
Total revenues 35,148 32,026 26,910
Product sales | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 25,656 23,301 19,272
Product sales | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues 9,492 8,725 7,638
Other revenues      
Disaggregation of Revenue [Line Items]      
Total revenues 1,603 1,398 1,280
Other revenues | U.S.      
Disaggregation of Revenue [Line Items]      
Total revenues 763 562 534
Other revenues | ROW      
Disaggregation of Revenue [Line Items]      
Total revenues $ 840 $ 836 $ 746